Why Moderna Has Become the Market's Favorite Hantavirus Stock -- Barrons.com

Dow Jones05-11

By Callum Keown

The chances of the hantavirus outbreak becoming another Covid-19 pandemic appear unlikely for now but the market is positioning itself for that outcome anyway -- through Moderna stock.

The stock jumped 7.2% to $58.25 in premarket trading Monday after a U.S. national tested positive for the Andes strain of hantavirus. The shares, which rose 12% on Friday, are on track for their highest close since October 2024, according to Dow Jones Market Data.

Moderna shares hit a 52-week closing low of $22.26 on Nov. 20, 2025 but has jumped 161% since then, as of Monday's premarket price.

The U.S. health department said one passenger on a repatriation flight has tested mildly positive for the virus, while another is currently experiencing mild symptoms. The Department of Health and Human Services $(HHS)$ said all 17 American citizens from the MV Hondius cruise ship are currently en route to the U.S.

The two passengers are traveling in the plane's biocontainment units "out of an abundance of caution," HHS said in a statement.

The company confirmed it was exploring a hantavirus treatment in a statement Thursday, describing its efforts as "early-stage and ongoing" and as part of a broader push to address emerging infectious diseases.

Write to Callum Keown at callum.keown@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

May 11, 2026 06:47 ET (10:47 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2634821288?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-11 18:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2634821288","market":"nz","top_or_hot":-1,"title":"Why Moderna Has Become the Market's Favorite Hantavirus Stock -- Barrons.com","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Callum Keown \n</p>\n<p>\n  The chances of the hantavirus outbreak becoming another Covid-19 pandemic appear unlikely for now but the market is positioning itself for that outcome anyway -- through <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> stock. \n</p>\n<p>\n  The stock jumped 7.2% to $58.25 in premarket trading Monday after a U.S. national tested positive for the Andes strain of hantavirus. The shares, which rose 12% on Friday, are on track for their highest close since October 2024, according to Dow Jones Market Data. \n</p>\n<p>\n  Moderna shares hit a 52-week closing low of $22.26 on Nov. 20, 2025 but has jumped 161% since then, as of Monday's premarket price. \n</p>\n<p>\n  The U.S. health department said one passenger on a repatriation flight has tested mildly positive for the virus, while another is currently experiencing mild symptoms. The Department of Health and Human Services <a href=\"https://laohu8.com/S/HHS\">$(HHS)$</a> said all 17 American citizens from the MV Hondius cruise ship are currently en route to the U.S. \n</p>\n<p>\n  The two passengers are traveling in the plane's biocontainment units \"out of an abundance of caution,\" HHS said in a statement. \n</p>\n<p>\n  The company confirmed it was exploring a hantavirus treatment in a statement Thursday, describing its efforts as \"early-stage and ongoing\" and as part of a broader push to address emerging infectious diseases. \n</p>\n<p>\n  Write to Callum Keown at callum.keown@dowjones.com \n</p>\n<p>\n   This content was created by Barron's, which is operated by Dow Jones &amp; Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 11, 2026 06:47 ET (10:47 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Has Become the Market's Favorite Hantavirus Stock -- Barrons.com</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Has Become the Market's Favorite Hantavirus Stock -- Barrons.com\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-11 18:47</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Callum Keown \n</p>\n<p>\n  The chances of the hantavirus outbreak becoming another Covid-19 pandemic appear unlikely for now but the market is positioning itself for that outcome anyway -- through <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> stock. \n</p>\n<p>\n  The stock jumped 7.2% to $58.25 in premarket trading Monday after a U.S. national tested positive for the Andes strain of hantavirus. The shares, which rose 12% on Friday, are on track for their highest close since October 2024, according to Dow Jones Market Data. \n</p>\n<p>\n  Moderna shares hit a 52-week closing low of $22.26 on Nov. 20, 2025 but has jumped 161% since then, as of Monday's premarket price. \n</p>\n<p>\n  The U.S. health department said one passenger on a repatriation flight has tested mildly positive for the virus, while another is currently experiencing mild symptoms. The Department of Health and Human Services <a href=\"https://laohu8.com/S/HHS\">$(HHS)$</a> said all 17 American citizens from the MV Hondius cruise ship are currently en route to the U.S. \n</p>\n<p>\n  The two passengers are traveling in the plane's biocontainment units \"out of an abundance of caution,\" HHS said in a statement. \n</p>\n<p>\n  The company confirmed it was exploring a hantavirus treatment in a statement Thursday, describing its efforts as \"early-stage and ongoing\" and as part of a broader push to address emerging infectious diseases. \n</p>\n<p>\n  Write to Callum Keown at callum.keown@dowjones.com \n</p>\n<p>\n   This content was created by Barron's, which is operated by Dow Jones &amp; Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 11, 2026 06:47 ET (10:47 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4501","symbol_name":"段永平概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2634821288","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2634821288","pubTimestamp":1778496420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"The chances of the hantavirus outbreak becoming another Covid-19 pandemic appear unlikely for now but the market is positioning itself for that outcome anyway -- through Moderna stock.The stock jumped 7.2% to $58.25 in premarket trading Monday after a U.S. national tested positive for the Andes strain of hantavirus. The shares, which rose 12% on Friday, are on track for their highest close since October 2024, according to Dow Jones Market Data.Moderna shares hit a 52-week closing low of $22.26 on Nov. 20, 2025 but has jumped 161% since then, as of Monday's premarket price.The U.S. health department said one passenger on a repatriation flight has tested mildly positive for the virus, while another is currently experiencing mild symptoms. The Department of Health and Human Services  said all 17 American citizens from the MV Hondius cruise ship are currently en route to the U.S.The two passengers are traveling in the plane's biocontainment units \"out of an abundance of caution,\" HHS said ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4501":"段永平概念","MRNA":"Moderna, Inc.","HHS":"Harte-Hanks","BK4551":"寇图资本持仓","MRNY":"MRNA期权收益策略ETF-YieldMax","BK4568":"美国抗疫概念","BK4588":"碎股","BK4009":"广告","BK4548":"巴美列捷福持仓","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4532":"文艺复兴科技持仓","MRNX":"Defiance Daily Target 2X Long MRNA ETF","BK4533":"AQR资本管理(全球第二大对冲基金)"},"translate_title":"为什么Moderna成为市场最喜欢的汉坦病毒股票--Barrons.com","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9,"HHS":1,"MRNX":0.6,"MRNY":0.6},"content_text":"By Callum Keown \n\n\n  The chances of the hantavirus outbreak becoming another Covid-19 pandemic appear unlikely for now but the market is positioning itself for that outcome anyway -- through Moderna stock. \n\n\n  The stock jumped 7.2% to $58.25 in premarket trading Monday after a U.S. national tested positive for the Andes strain of hantavirus. The shares, which rose 12% on Friday, are on track for their highest close since October 2024, according to Dow Jones Market Data. \n\n\n  Moderna shares hit a 52-week closing low of $22.26 on Nov. 20, 2025 but has jumped 161% since then, as of Monday's premarket price. \n\n\n  The U.S. health department said one passenger on a repatriation flight has tested mildly positive for the virus, while another is currently experiencing mild symptoms. The Department of Health and Human Services $(HHS)$ said all 17 American citizens from the MV Hondius cruise ship are currently en route to the U.S. \n\n\n  The two passengers are traveling in the plane's biocontainment units \"out of an abundance of caution,\" HHS said in a statement. \n\n\n  The company confirmed it was exploring a hantavirus treatment in a statement Thursday, describing its efforts as \"early-stage and ongoing\" and as part of a broader push to address emerging infectious diseases. \n\n\n  Write to Callum Keown at callum.keown@dowjones.com \n\n\n   This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 06:47 ET (10:47 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2634821288","isCrawlerRequest":true}